Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

NCT00019357 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: therapeutic autologous lymphocytes
BIOLOGICAL: therapeutic tumor infiltrating lymphocytes

Sponsor

National Cancer Institute (NCI)